交易中 04-01 10:14:15 美东时间
+0.315
+0.77%
今日重点评级关注:HC Wainwright & Co.:维持Atossa Therapeutics"买入"评级,目标价从7美元升至25美元;Needham:维持Nkarta"买入"评级,目标价从10美元升至11美元
03-27 10:22
Keefe, Bruyette & Woods analyst Ryan Krueger reinstates CNO Finl Group (NYSE:CNO) with a Market Perform and announces $46 price target.
03-27 00:40
华盛资讯2月25日讯,康塞科公布2025财年年度业绩,公司年度营收44.87亿美元,同比增长0.9%,归母净利润2.29亿美元,同比下滑45.5%。
02-25 08:40
今日重点评级关注:杰富瑞:上调BioAge Labs评级至"买入",目标价从9美元升至62美元;RBC Capital:维持COMPASS Pathways Plc Sponsored ADR"跑赢大市"评级,目标价从21美元升至22美元
02-19 16:21
CNO survey finds one in three middle-income Americans ages 50 to 85 are less confident in their retirement plans as confidence in future of Social Security and Medicare weakens CARMEL, Ind.,...
02-18 22:15
Evercore ISI Group analyst Thomas Gallagher maintains CNO Finl Group (NYSE:CNO) with a Underperform and raises the price target from $42 to $43.
02-18 22:08
华盛资讯2月6日讯,康塞科公布2025财年Q4业绩,公司Q4营收11.43亿美元,同比增长4.2%,归母净利润0.93亿美元,同比下滑49.2%。
02-06 16:06
CNO Finl Group (NYSE:CNO) reported quarterly earnings of $1.47 per share which beat the analyst consensus estimate of $1.21 by 21.79 percent. This is a 12.21 percent increase over earnings of $1.31 per share from the
02-06 05:19
Steve Janoson promoted to Senior Vice President, Direct and Independent Distribution; Rachel Spehler promoted to Senior Vice President, Deputy General Counsel and Secretary CARMEL, Ind., Jan...
01-22 06:00
今日重点评级关注:Truist Securities:维持拜玛林制药"买入"评级,目标价从80美元升至100美元;HC Wainwright & Co.:维持Savara"买入"评级,目标价从8美元升至10美元
2025-12-24 11:17